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ABSTRACT 
Recent genetic studies for suicidality, including four independent GWAS, have not 
reproduced each other’s top implicated genes. While arguments of heterogeneity, 
methodology, and sample sizes can be invoked, heterogeneity is a feature, not a “bug” 
(as is well understood in biology and in personalized medicine). A comprehensive body 
of work on blood biomarkers for suicidality has previously been published by our group. 
We examine the issue of reproducibility using these different approaches, and provide 
reassuring evidence for convergence of findings, as well as some generalizable insights. 
“To know things as they are is better than to believe things as they seem” 
- Tom Wicker
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Our group has published a series of papers in Molecular Psychiatry identifying blood gene 
expression biomarkers that track suicidal ideation in a discovery cohort, are validated in 
a suicide completers cohort, and predict suicidal ideation state, and future hospitalizations 
for suicidality, in independent cohorts [1,2,3]. 
Since our last publication in 2017, a series of 4 GWAS of suicidality (ideation, attempts) 
[4,5,6,7], as well as a family based genetic study of suicide completers [8] and a family 
based genetic study in suicide attempters [9], have been published, in Molecular 
Psychiatry and other journals. 
We endeavored to examine the issue of convergence of those studies with our previous 
work (Table 1). Of note, there was no overlap between the top genes implicated by these 
different recent genetic studies, which raises the issue of apparent lack of reproducibility 
in the field. We compared the list of top genes implicated by each of the recent genetic 
studies (genes that were associated with loci/SNPs that were statistically significant 
and/or were highlighted/discussed by the authors in their paper) [4,5,6,7,8,9], with the list 
of candidate biomarkers that survived the initial whole-genome discovery step in our 
previous published studies, before any literature-based prioritization. We sought to see if 
any of the top genes from the recent genetic studies have functional evidence of tracking 
suicidal ideation in our blood gene expression biomarker discovery studies. 
 
 
 
 
 
 
 
 
 
 
 
Table 1. 
Genetic studies Biomarker studies 
Study 
Phenotype 
(Discovery cohorts) 
Top 
genes 
implicated 
Niculescu et al. [3] 
Suicidal 
Ideation (Universal 
Within-
subject n = 66) 
Niculescu et al. 
[3] 
Suicidal 
Ideation (Male 
bipolar 
Within-
subject n = 20) 
Levey et al. 
[2] 
Suicidal 
Ideation 
(Females 
Within-
subject n = 12) 
Niculescu et al. 
Suicidal 
Ideation (Males 
[1] Within-
subject 
n = 37) 
GWAS           
Levey et al. [7] 
Severity of suicide 
attempt 
(Yale-Penn European 
Americans (EAs, n = 2439) 
and African Americans 
(AAs, n = 3881) 
LDHB 
ARNTL2-
AS1 
FAH 
CTXND1 
PGBD5 
NARG2 
PHLDB2 
LDHB 
PHLDB2 
PGBD5 
PGBD5 FAH PHLDB2 PHLDB2 
Kimbrel et al. [5] 
Suicide ideation, 
Suicide attempt 
(US Military Veterans; 
Suicide 
ideation n = 138/1433; 
Suicide 
attempt n = 122/1447) 
KCNMB2 
ABI3BP 
LUZP2 
KCNMB2 
ABI3BP LUZP2 KCNMB2 
ABI3BP 
LUZP2 
Erlangsen et al. [6] 
Suicide attempt (Danish 
population, n = 6024/44,240) 
PDE4B 
FAM114A2 
RBFOX2 
PREX1 
KIAA1549L 
PDE4B 
FAM114A2 
RBFOX2 
PDE4B 
FAM114A2 
RBFOX2 
PDE4B RBFOX2 PREX1 
Stein et al. [4] 
Suicide attempt 
(US Military 
n = 473/9778) 
MRAP2 
CEP162 CEP162   CEP162 CEP162 
 
 
Genetic studies Biomarker studies 
Family-based genetic 
studies           
Coon et al. [8] 
Suicide completers 
(43 Utah high-risk families, 
with an average of 6.2 
suicides per family) 
207 genes 
72/207 (34.8%) 
ACSL6 
LACTB 
PRKAG2 
AGBL2 
GIMAP1 
GIMAP7 
HTR2A 
al. 
63/207 (30.4%) 
NUB1 
MTNR1A 
STAT1 
SP140 
ABCB8 
SLC7A1 
HTR2A 
al. 
89/207 (43%) 
FNDC3A 
ETV2 
ADAM10 
RCBTB2 
CYP4V2 
GIMAP4 
HTR2A 
al. 
65/207 (31.4%) 
SLC7A1 
GIMAP5 
AQP9 
ALDH1A2 
PRKAG2 
RHEB 
MSRA 
al. 
Sokolowski et al. [9] 
Suicide attempt 
(Ukraine population, family 
based study, trios, 
N = 498 offspring with 
medically severe suicide 
attempt) 
CACHD1 
CACNA1D 
CR1 
CRISPLD2 
GABRR2 
GNAS 
GRIN2B 
GSN 
MAP3K9 
PFN2 
PRSS3 
RALGPS1 
RETREG1 
RNASEH2B 
SYTL3 
TSPAN2 
UBE2H 
CACNA1D 
CR1 
GRIN2B 
GSN 
RALGPS1 
RNASEH2B 
SYTL3 
UBE2H 
CR1 
GNAS 
GSN 
MAP3K9 
RALGPS1 
RNASEH2B 
SYTL3 
TSPAN2 
UBE2H 
PRSS3 
RALGPS1 
TSPAN2 
CACNA1D 
CR1 
CRISPLD2 
GNAS 
GSN 
RALGPS1 
RNASEH2B 
SYTL3 
TSPAN2 
UBE2H 
 
As illustrated in Table 1, there is a remarkable overlap with the universal candidate 
biomarkers described in our 2017 study (where we combined gender and psychiatric 
diagnosis). The overlap is even greater when we include all of our previous 
studies/analyses, conducted separately in males, females, and male bipolars. While 
statistical calculations could be made, the over-representation in the overlaps shown in 
 
 
Table 1 is self-evident (as a small number of genetic findings are highlighted in each 
genetic study, and a fraction of the genome has gene expression changes tracking 
suicidality in each of the biomarker studies). The important points are biological 
(functional evidence), and methodological (reproducibility). Reproducibility of findings, 
across independent laboratories, using independent cohorts, and different 
methodologies, is the litmus test in science [10]. These results are thus reassuring for the 
field. 
On a methodological note, it is possible that different approaches have different sample 
size requirements, and different challenges in accruing those sample sizes. As we show 
here, our within-subject longitudinal gene expression studies tracking a quantitative 
phenotype (severity of suicidal ideation), conducted with dozens of subjects, are 
comparable to larger family based genetic studies for a strong categorical phenotype 
(suicide completion), with hundreds of subjects, and to case-control genetic (GWAS) 
studies conducted with thousands or tens of thousands of subjects. 
Of interest, the genes that overlap between our biomarker studies and the genetic studies 
were by and large not among the top predictive biomarkers for suicidality identified by us 
at the end of our biomarker studies [1,2,3]. It is possible that SNP-level signal strength 
and reproducibility, as are assessed in GWAS, tag genes that are more invariant and 
perhaps involved in less-specific, housekeeping type functions, as opposed to the genes 
identified by expression studies looking at functional ability to track and predict a 
phenotype. The latter may identify genes that are more specific for a phenotype and more 
variable at a SNP level due to evolutionary fine tuning and adaptation to the environment, 
especially in the case of complex behavioral phenotypes like suicidality. 
Suicidality (ideation, attempts, completions) is a heterogeneous phenotype, likely on a 
spectrum of severity [3], with a strong environmental component, and with biological 
gender and diagnostic differences [1,2,3]. It is likely that our blood biomarkers reflect the 
effects of many different SNPs, are at the interface of genes and environment, and thus 
capture more of the biology. Beyond their practical applicability, they can serve as a 
Rosetta Stone and integrator of independent genetic studies [11]. 
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